Multi-Omics Characterization of Peripheral Blood Molecular Profiles in Hypertensive Aging Ailuropoda melanoleuca with...

Hypertension threatens the health of aging captive giant pandas, yet its molecular signatures remain poorly characterized. Here, multi-omics sequencing was applied to explore the molecular regulatory process of hypertension and the pharmacodynamic effect of levamlodipine on this endangered species. Six aged giant pandas were divided into hypertensive and normotensive groups (three hypertensive and three normotensive pandas) based on clinical phenotypes and blood pressure measurements. A multi-omics approach was employed, including blood RNA-seq, Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq), single-cell RNA-seq (scRNA-seq) of peripheral blood mononuclear cells, and time-series RNA-seq following levamlodipine administration. Our transcriptomic analysis revealed a statistically significant decline in ACE2 transcript abundance (Padj < 0.05), which suggests a possible shift in renin-angiotensin system signaling linked to hypertensive status in giant pandas. Single-cell analysis of 88,693 cells revealed that hypertension-associated genes were predominantly enriched in monocytes and T cells, implicating immune cell activation. Time-dependent transcriptional changes after levamlodipine administration. Temporal gene dynamics showed early activation of metabolic pathways followed by delayed inhibition of ion channels and calcium signaling. This study provides a transcriptional molecular perspective into the pathogenesis of hypertension in giant pandas, which is conducive to developing more effective antihypertensive treatment strategies, thereby protecting the health of this endangered species.